Arbutus Biopharma Corp Operating Lease, Liability, Current
Arbutus Biopharma Corp (ABUS) had Operating Lease, Liability, Current of $514.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseLiabilityCurrent · last filed 2026-08-12
- 2026-06-30: Operating Lease, Liability, Current $514.00K.
- 2026-03-31: Operating Lease, Liability, Current $631.00K.
- 2025-12-31: Operating Lease, Liability, Current $547.00K.
- 2025-09-30: Operating Lease, Liability, Current $531.00K.
| Period end | Operating Lease, Liability, Current |
|---|---|
| 2026-06-30 | $514.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $631.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $547.00K 10-Q · filed 2026-08-12 |
| 2025-09-30 | $531.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $514.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $563.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $483.00K 10-K · filed 2026-03-23 |
| 2024-09-30 | $468.00K 10-Q · filed 2024-11-06 |
| 2024-06-30 | $453.00K 10-Q · filed 2024-08-08 |
| 2024-03-31 | $502.00K 10-Q · filed 2024-05-02 |
| 2023-12-31 | $425.00K 10-K · filed 2025-03-27 |
| 2023-09-30 | $412.00K 10-Q · filed 2023-11-07 |
| 2023-06-30 | $397.00K 10-Q · filed 2023-08-03 |
| 2023-03-31 | $446.00K 10-Q · filed 2023-05-04 |
| 2022-12-31 | $372.00K 10-K · filed 2024-03-05 |
| 2022-09-30 | $360.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $377.00K 10-Q · filed 2022-08-04 |
| 2022-03-31 | $439.00K 10-Q · filed 2022-05-05 |
| 2021-12-31 | $383.00K 10-K · filed 2023-03-02 |
| 2021-09-30 | $386.00K 10-Q · filed 2021-11-04 |
| 2021-06-30 | $357.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $432.00K 10-Q · filed 2021-05-05 |
| 2020-12-31 | $390.00K 10-K · filed 2022-03-03 |
| 2020-09-30 | $378.00K 10-Q · filed 2020-11-05 |
| 2020-06-30 | $364.00K 10-Q · filed 2020-08-07 |
| 2020-03-31 | $408.00K 10-Q · filed 2020-05-11 |
| 2019-12-31 | $340.00K 10-K · filed 2021-03-04 |
| 2019-09-30 | $329.00K 10-Q · filed 2019-11-06 |
| 2019-06-30 | $376.00K 10-Q · filed 2019-08-05 |
| 2019-03-31 | $599.00K 10-Q · filed 2019-05-06 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |